MS
Satellos Bioscience Inc. Common Stock (MSLE)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$6.50
-5.52%
Mkt Cap $15.01M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$19.67
Range $18.00 – $23.00
Implied Upside
+202.6%
Consensus $19.67 vs current $6.50